Neurosteroids affect neurotransmission through action at the membrane ion-gated receptors and at other neurotransmitter receptors. 3a-Hydroxy-5a-pregnan-20-one (allopregnanolone, AP), a representative neurosteroid, binds to the gaminobutyric acid type A (GABA A ) receptors with a high affinity and positively modulates the action of GABA at these receptors, and hence elicits marked anticonvulsant, antidepressant and anxiolytic effects.
Neurosteroids affect neurotransmission through action at the membrane ion-gated receptors and at other neurotransmitter receptors. 3a-Hydroxy-5a-pregnan-20-one (allopregnanolone, AP), a representative neurosteroid, binds to the gaminobutyric acid type A (GABA A ) receptors with a high affinity and positively modulates the action of GABA at these receptors, and hence elicits marked anticonvulsant, antidepressant and anxiolytic effects. 1) Under stressful conditions, the brain rapidly synthesizes progesterone (PROG) and subsequently converts it to AP to raise the threshold of brain excitability.
2)
The two-step metabolism of PROG produces AP through the actions of the enzymes, 5a-reductase (rate-limiting step) and 3a-hydroxysteroid dehydrogenase (3a-HSD). Two distinct 5a-reductase isozymes, types 1 (predominant form in the brain) and 2 (predominant form in the periphery), are found across mammalian species.
3) Finasteride [17a-(N-tbutyl)carbamoyl-4-aza-5a-androst-1-en-3-one, FIN] is the 5a-reductase inhibitor that has received clinical approval for the treatment of human benign prostatic hyperplasia and androgenetic alopecia. Both isozymes of the 5a-reductase in the rodent demonstrate comparable inhibition following FIN exposure; FIN can inhibit the 5a-reductase activity in the central nervous system as well as in the periphery. 4) Based on this, FIN has also been used to manipulate the brain AP level for characterization of its physiological functions and the mechanism by which it affects the brain functions, and to analyze the exact mechanisms of action of psychotropic agents, whose antidepressant and anxiolytic effects are inferred to occur through an increase in the brain AP synthesis. 5, 6) Thus, FIN is an indispensable tool in the development of new psychotropic agents targeting neurosteroidogenesis as well as in basic neurosteroid research. On the contrary, the treatment with FIN may induce alternative metabolic pathways, such as 3a-reduction, 20a-reduction and 21-hydroxylation, in the PROG metabolism (Fig. 1) , and the generated metabolites may consequently affect the central nervous system and modulate the emotional state. However, there is no report that examines the changes in the brain levels of the PROG and its metabolites following treatment with FIN. Even for AP, a detailed FIN-evoked change in the brain concentration has not been elucidated.
Based on this background information, the objectives of this study are to develop liquid chromatography-tandem mass spectrometric (LC-MS/MS) methods that enable the determination of trace amounts of the brain PROG and its down stream conversion products [AP, 3a-dihydroprogesterone (3a-DHP), 20a-dihydroprogesterone (20a-DHP) and 11-deoxycorticosterone (DOC)] (Fig. 1) and to determine the influence of FIN on the brain steroid levels and metabolism in rats under the stressful condition.
MATERIALS AND METHODS

Materials and
Reagents AP, 3a-DHP, 3b-DHP and 20a-DHP were obtained from Steraloids (Newport, RI, U.S.A.). PROG and DOC were purchased from Tokyo Kasei Kogyo (Tokyo, Japan) and Nacalai Tesque (Kyoto, Japan), re- spectively. [17a,21,21,21-2 H 4 ]-AP (D 4 -AP) was that used in a previous study 7) and used as the internal standard (IS) for the AP quantification. 3b-DHP was used as the IS for the 3a-DHP quantification. [2, 2, 4, 6, 6 ,17a,21,21,21-2 H 9 ]-PROG (D 9 -PROG) was purchased from CDN Isotopes (PointeClaire, Quebec, Canada) and used as the IS for the PROG, 20a-DHP and DOC quantification. Each steroid was dissolved in and diluted with ethanol to prepare the standard solutions. 2-Hydroxypropyl-b-cyclodextrin (b-CD) was purchased from Wako Pure Chemical Industries (Osaka, Japan). Strata-X cartridges (60 mg adsorbent; Phenomenex, Torrance, CA, U.S.A.) were successively washed with ethyl acetate (2 ml), methanol (2 ml) and water (2 ml) prior to use. Bond Elut Si cartridges (500 mg adsorbent; Varian, Harbor, CA, U.S.A.) were successively washed with ethyl acetate (4 ml) and hexane (4 ml) prior to use. All other reagents and solvents were of analytical grade.
Animals Male Wistar strain rats (7-weeks old, 180-220 g body weight, Japan S.L.C., Hamamatsu, Japan) were maintained under an artificial 12 h light/12 h dark cycle (light on 08:00-20:00). The rats were transferred to the laboratory and then left unrestrained in a quiet place for 2 h before the experiments. 5% b-CD in saline (w/v, 1 ml, vehicle, nϭ5) or FIN (0.5, 2.0 or 10 mg/kg, nϭ5 per group) was intraperitoneally (i.p.) administered to the rats. The solution of FIN was made in 5% b-CD in saline and 1 ml of which was administered. One hour after the administration of the vehicle or FIN, the rats were immobilized on their backs on a board for 20 min. After immobilization, the rats were unrestrained for 30 min and then euthanized. In order to examine the stress-induced increase in the brain steroids, 5 rats were euthanized by decapitation 60 min after the vehicle injection; these were labeled the unstressed rats in this study. All treatments were performed between 13:00 h and 15:00 h. All animal care and use were approved by the Institutional Animal Care and Use Committee of Kanazawa University.
Statistical Analysis The statistical analyses were performed using the Kruskal-Wallis test followed by the Steel-Dwass test. A p value of Ͻ0.05 was considered statistically significant.
Determination of AP in Rat Brains
The steroids including AP were extracted from the rat brain tissue with methanol-acetic acid (99 : 1, v/v) using a previously reported method.
7) The brain extract was diluted to adjust the concentrations of 100 mg tissue/ml with methanol-acetic acid (99 : 1, v/v) and stored at Ϫ20°C prior to use.
After the addition of D 4 -AP (200 pg) and water (1 ml), 0.5 ml of the brain extract (corresponding to 50 mg of brain tissue) was passed through a Strata-X cartridge. After washing with water (2 ml) and methanol-water (3 : 2, v/v, 2 ml), the steroids were eluted with ethyl acetate (1 ml). After evaporation of the eluent from the cartridge, the residue was dissolved in hexane-ethyl acetate (3 : 1, v/v, 0.2 ml) and further purified using a Bond Elut Si cartridge. After washing with hexane (3 ml) and hexane-ethyl acetate (3 : 1, v/v, 3 ml), the steroids were eluted with ethyl acetate-hexane (3 : 2, v/v, 2 ml). After evaporation, the residue was subjected to derivatization with 2-hydrazino-1-methylpyridine (HMP) as previously reported.
7) The derivatized steroids were dissolved in methanol-water (1 : 1, v/v, 30 ml), 10 ml of which was subjected to LC-electrospray ionization (ESI)-MS/MS. The LC-MS/MS instrument and conditions were the same as those previously reported. 7) The quantification was based on the selected reaction monitoring (SRM) mode using the characteristic transition of the HMP derivatives ([M] ϩ →m/z 108). Determination of 3a a-DHP in Rat Brains The brain extract (100 mg tissue/ml) was prepared as described above. After the addition of 3b-DHP (IS, 1.0 ng), which was not detected in the brains, and water (1 ml), 1.0 ml of the extract (corresponding to 100 mg of brain tissue) was purified using Strata-X and Bond Elut Si cartridges in the same way for the determination of AP. After evaporation of the eluent from the cartridge, the residue was dissolved in methanol-water (1 : 1, v/v, 100 ml), 25 ml of which was subjected to LC-ESI-MS/MS [instrument; Applied Biosystems API 4000 Q TRAP triple quadrupole-mass spectrometer connected to an Agilent 1200 series chromatograph (Palo Alto, CA, U.S.A.), analytical column; A J'sphere ODS H-80 column (4 mm, 150ϫ2.0 mm i.d.; YMC, Kyoto), column temperature; 40°C, mobile phase; methanol-10 mM ammonium formate (18 : 7, v/v), flow rate; 0.2 ml/min, declustering potential; 45 V, entrance potential; 10 V, ion spray voltage; 5 kV, curtain gas; 35 psi, ion source gas 1; 90 psi, ion source gas 2; 80 psi, turbo gas temperature; 400°C]. Nitrogen was used as the collision gas in the SRM mode with a collision energy of 34 eV and a col- 
Determination of PROG, 20a a-DHP and DOC in Rat Brains
The brain extract (100 mg tissue/ml) was prepared as already described. After the addition of D 9 -PROG (200 pg) and water (3 ml), 0.2 ml of the extract (corresponding to 20 mg of brain tissue) was passed through a Strata-X cartridge. After washing with water (3 ml), acetonitrile-water (3 : 7, v/v, 2 ml) and hexane (1 ml), the steroids were eluted with ethyl acetate (2 ml). After evaporation of the eluent from the cartridge, the residue was dissolved in methanolwater (1 : 1, v/v, 75 ml), 25 ml of which was subjected to LC-ESI-MS/MS. The LC-MS/MS instrument and conditions were the same as those for the determination of 3a-DHP except for the following parameters: declustering potential; 65 (PROG), 70 (DOC) or 80 V (20a-DHP), ion source gas 1; 65 psi, ion source gas 2; 85 psi, turbo gas temperature; 650°C. The SRM was performed with a collision energy of 34 eV and a collision cell exit potential of 7 V. 
→100.2.
Calibration Curves The brain extract (15 ml) was stirred overnight with activated charcoal (1.5 g, Norit EXW, Nacalai Tesque) and then centrifuged at 1500 g (4°C, 30 min). The supernatant, in which any steroids of interest were not detected by our methods, was spiked with respective steroids and ISs and then the calibration curves were constructed by plotting the peak area ratios of the respective steroids to the respective ISs versus the concentrations of the respective steroids.
RESULTS AND DISCUSSION
Assay Methods LC coupled with ESI-MS is currently being used for the characterization and determination of neurosteroids due to its specificity, versatility and simultaneous multi-analyte quantification capability. [7] [8] [9] The ionization efficiencies of steroids depend on their chemical structures; the 3-oxo-4-ene-steroids (PROG, 20a-DHP and DOC) are easily ionized during the ESI, 8 ) the 3a/b-hydroxy-4-ene-steroids (3a-DHP) are fairly ionizable, while the 3a/b-hydroxy-5a-reduced-steroids (AP) have extremely low responses for ESI-MS. 7) Therefore, these steroids were separately analyzed according to their structures in this study; the 3-oxo-4-enesteroids and 3a-DHP were analyzed as their intact forms, while derivatization was required to determine the physiological concentration of AP.
For the quantification of AP, the method that we had previously developed 7) was used with some modifications, i.e., a larger sample volume and an additional purification step using a normal-phase solid-phase extraction (SPE) cartridge. Due to these modifications, the limit of quantification (LOQ) was improved to 0.1 ng/g tissue from 0.25 ng/g tissue, 7) and any endogenous components, such as other steroids and lipoidal compounds, did not interfere with the AP quantification.
The method for the determination of 3a-DHP was newly developed. For the ESI-MS operating in the positive-ion mode, 3a-DHP and IS (3b-DHP) provided their [MϩHϪ H 2 O] ϩ as the base peak ions (Fig. 2a) . The product ion mass spectra of the steroids employing the respective [MϩHϪ H 2 O] ϩ as the precursor ions and a 34-eV collision energy are shown in Fig. 2b , in which a characteristic product ion with a satisfactory intensity was observed at m/z 81.2. The putative fragmentation that causes the product ion at m/z 81 is also illustrated in Fig. 2b . Based on these results, the SRM mode using the [MϩHϪH 2 O] ϩ and the ion at m/z 81.2 as the precursor and product ions, respectively, was employed in the following studies. A satisfactory separation of 3a-DHP and IS was achieved within 16 min using a J'sphere ODS H-80 column with the mobile phase of methanol-10 mM ammonium formate (18 : 7, v/v); 3a-DHP, retention time (t R ) 13.9 min and IS, t R 11.6 min (Fig. 2c) . Under these LC conditions, 3a-DHP and IS were well separated from pregnenolone (t R 12.4 min), which is the predominant brain steroid under stressful conditions. The pretreatment procedure that had been developed for the AP assay was adopted for the 3a-DHP quantification. This procedure provided satisfactory recovery rates (Ͼ70%) of the target steroid and IS. Furthermore, in the chromatograms obtained from the brains of unstressed rats, there was no peak at the elution positions of 3a-DHP and IS (chromatograms not shown), demonstrating that the pretreatment procedure was effective for removing the inferring factors derived from the brain matrix. The relative standard deviation (RSD) and relative error of the back-calculated concentration at the minimum point (0.1 ng/g tissue) on the calibration curve were 4.0% and 6.0%, respectively. The peak of 3a-DHP at this concentration was clearly observed with a signal to noise ratio of more than 5. Based on these results, the LOQ of the brain 3a-DHP was determined to be 0.1 ng/g tissue, when a 100-mg brain tissue was used. Thus, our method can precisely and accurately quantify 0.1 ng/g tissue of the brain 3a-DHP, though no LC-MS method has heretofore been reported for the brain 3a-DHP due to its low concentration.
For quantification of the 3-oxo-4-ene-steroids, some modifications were made to the previous assay.
8 ) The improved method employed a very simple pretreatment procedure, i.e., a one-step SPE, and the recovery rates of all the steroids were over 90%, whereas the previous method required two steps SPE. 8) This method enables the simultaneous quantification of PROG, 20a-DHP and DOC without interferences by any endogenous components.
The results of the validation tests for the respective assays are summarized in Table 1 ; as is obvious from this table, all the methods allowed the reproducible and accurate quantification of the brain neurosteroids.
Influence of FIN on Brain Neurosteroid Levels and Metabolism Although the brain AP level is extremely low (practically none) under normal conditions, it is significantly elevated by acute stress paradigms, such as immobilization, 7) forced swimming 10) and CO 2 inhalation. 11) In this study, the influence of FIN on the brain neurosteroid levels was examined using rats exposed to immobilization, in which the AP synthesis was significantly enhanced.
Rats were intraperitoneally injected with vehicle (saline) or FIN 1 h prior to the immobilization, and then the brain neurosteroid levels were determined using the developed LC-MS/MS methods. The results are shown in Fig. 3 . The AP level of the stressed rat dose-dependently decreased by the FIN treatment, and thus, that in the 10 mg/kg of FIN-injected rat was less than 10% of that for the vehicle-injected rat (Fig.  3a) . Our previous study demonstrated that the administration of FIN (10 mg/kg, i.p.) also depleted the neuroactive androgen, 5a-androstane-3a,17b-diol (3a,5a-Adiol), 12) which is also the potent positive modulator of the GABA A receptors, in rat brains. In the previously reported animal studies, FIN at doses ranging from 25-150 mg/kg have typically been administered.
3) However, our studies showed that a 10 mg/kg dose of FIN can almost completely deplete the GABAergic neurosteroids (AP and 3a,5a-Adiol) in the rat brains.
3a-DHP has been reported to enhance the effect of GABA by potentiating the GABA-induced Cl Ϫ conductance, 13) and this study demonstrates that the brain level of 3a-DHP is also increased by the acute stress (Fig. 3b) . Based on these data, this steroid would also work as an endogenous anxiolytic agent under stressful conditions. Therefore, we expected that in the FIN-treated rats, the synthesis of 3a-DHP might be increased in order to utilize it as the alternative to AP in the defensive response to acute stress, but no change was found in its brain level by the administration of FIN (Fig. 3b) . It has been known that both the rat 3a-HSD and the human type 2 brain 3a-HSD convert PROG to 3a-DHP. 14) As the type 2 brain 3a-HSD mRNA is found in different amounts in different regions of the brain (type 2 brain 3a-HSD mRNA is predominately expressed in the thalamus, subthalamic nuclei and amygdala), 15) the 3a-DHP production may occur in specific regions of the brain. Therefore, a further examination analyzing the regional level changes in 3a-DHP is required to arrive at a reliable conclusion.
It has been known that the brain PROG, 20a-DHP and DOC levels are also increased by acute stress 8, 11) and similar results were reproduced in this study (Figs. 3c-e) . Although there were no changes in the brain PROG and DOC levels by the FIN treatment (Figs. 3c, e ), the 20a-DHP level in the rats administered with 10 mg/kg of FIN was significantly higher than that in the saline-administered rats (Fig. 3d) . These data indicate that the 20a-reduction is promoted when the 5a-reduction pathway is inhibited during the PROG metabolism in the brain. Although the biological significance of 20a-DHP in the brain is still not well elucidated, it is thought to be a catabolic metabolite to be excreted from the target organ or tissue. In humans, aldo-keto reductase 1C1 (AKR1C1) works as the 20a-HSD for PROG and AP, and it is thought that this enzyme decreases the AP concentrations in the brain by inactivating AP and eliminating its precursor, PROG, from the synthetic pathways.
16) The 21-hydroxylation of PROG catalyzed by the cytochrome P450 2D isoforms is also considered to be involved in the regulation of the brain neurosteroid contents.
17) The present study demonstrates that the rat brain decreases the accumulated PROG by its conversion into 20a-DHP rather than into DOC. a) The intra-and inter-assay precisions were evaluated by analyzing 5 replicates of a brain sample on 1 d and over 5 d, respectively. The brain sample used for the determination of the assay precisions contained 0.81 ng/g tissue of AP, 0.20 ng/g tissue of 3a-DHP, 14.8 ng/g tissue of PROG, 0.50 ng/g tissue of 20a-DHP and 14.3 ng/g tissue of DOC. b) The assay accuracy was evaluated by determining the analytical recovery rates, which were defined as F/(F 0 ϩA)ϫ100 (%); F is the concentration of a steroid in the spiked sample, F 0 is the concentration of a steroid in the unspiked sample and A is the spiked concentration. Data represent ranges of analytical recoveries (nϭ4). c) Recovery rate during the pretreatment (meanϮS.D., nϭ5). d) Correlation coefficient.
CONCLUSION
In this study, we developed LC-MS/MS methods that enable the reproducible and accurate determination of trace amounts of brain neurosteroids. The animal studies using these methods clarified the changes in the brain neurosteroid levels due to the FIN treatment; a 10 mg/kg dose of FIN can almost completely deplete AP in the rat brains, and 20a-DHP is enhanced when the 5a-reduction pathway is inhibited during the PROG metabolism in the brains.
